Tirzepatide Once Weekly for the Treatment of Obesity

Jastreboff et al. (Sat,) studied this question.

www.synapsesocial.com/papers/695c4b7403da22d857ec865e — DOI: https://doi.org/10.1056/nejmoa2206038

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept· 2018 · 805 citations
2. 8. Obesity Management for the Treatment of Type 2 Diabetes:<i>Standards of Medical Care in Diabetes—2020</i>· 2019 · 148 citations
3. Obesity Pathogenesis: An Endocrine Society Scientific Statement· 2017 · 696 citations
4. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline· 2015 · 1,292 citations
5. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis· 2021 · 329 citations